| 标题 |
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hematological Oncology 作者:Francesco Passamonti; Vikas Gupta; Bruno Martino; Lynda Foltz; Andrey Zaritskey; et al 出版日期:2021-07-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)